Abbott India has informed that the Board at its Meeting held on September 29, 2016 approved the appointment of Ambati Venu as the Additional Director on the Board and as the Managing Director of the Company for a term of 5 years effective September 29, 2016, subject to approval from the Central Government and the Shareholders of the Company. Ambati does not hold any shares in the Company and also not related to any of the Board Directors of the Company.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1672.40 |
| Dr. Reddys Lab | 1220.40 |
| Cipla | 1234.65 |
| Zydus Lifesciences | 930.80 |
| Lupin | 2312.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: